Literature DB >> 36267263

Characteristics and outcomes of culture-negative prosthetic joint infections from the Prosthetic Joint Infection in Australia and New Zealand Observational (PIANO) cohort study.

Sarah Browning1,2, Laurens Manning3,4, Sarah Metcalf5, David L Paterson6, James O Robinson7,8,9, Benjamin Clark3, Joshua S Davis1,2,10.   

Abstract

Introduction: Culture-negative (CN) prosthetic joint infections (PJIs) account for approximately 10 % of all PJIs and present significant challenges for clinicians. We aimed to explore the significance of CN PJIs within a large prospective cohort study, comparing their characteristics and outcomes with culture-positive (CP) cases.
Methods: The Prosthetic joint Infection in Australia and New Zealand Observational (PIANO) study is a prospective, multicentre observational cohort study that was conducted at 27 hospitals between 2014 and 2017. We compared baseline characteristics and outcomes of all patients with CN PJI from the PIANO cohort with those of CP cases. We report on PJI diagnostic criteria in the CN cohort and apply internationally recognized PJI diagnostic guidelines to determine optimal CN PJI detection methods.
Results: Of the 650 patients with 24-month outcome data available, 55 (8.5 %) were CN and 595 were CP. Compared with the CP cohort, CN patients were more likely to be female (32 (58.2 %) vs. 245 (41.2 %); p   =  0.016), involve the shoulder joint (5 (9.1 %) vs. 16 (2.7 %); p   =  0.026), and have a lower mean C-reactive protein (142 mg L - 1 vs. 187 mg L - 1 ; p   =  0.016). Overall, outcomes were superior in CN patients, with culture negativity an independent predictor of treatment success at 24 months (adjusted odds ratio, aOR, of 3.78 and 95 %CI of 1.65-8.67). Suboptimal diagnostic sampling was common in both cohorts, with CN PJI case detection enhanced using the Infectious Diseases Society of America PJI diagnostic guidelines. Conclusions: Current PJI diagnostic guidelines vary substantially in their ability to detect CN PJI, with comprehensive diagnostic sampling necessary to achieve diagnostic certainty. Definitive surgical management strategies should be determined by careful assessment of infection type, rather than by culture status alone. Copyright:
© 2022 Sarah Browning et al.

Entities:  

Year:  2022        PMID: 36267263      PMCID: PMC9562689          DOI: 10.5194/jbji-7-203-2022

Source DB:  PubMed          Journal:  J Bone Jt Infect        ISSN: 2206-3552


  24 in total

1.  Comparison of infection control rates and clinical outcomes in culture-positive and culture-negative infected total-knee arthroplasty.

Authors:  Young-Hoo Kim; Sourabh S Kulkarni; Jang-Won Park; Jun-Shik Kim; Hyun-Keun Oh; Devarshi Rastogi
Journal:  J Orthop       Date:  2015-02-17

Review 2.  A comprehensive review of the diagnosis and management of prosthetic joint infections in the absence of positive cultures.

Authors:  Monisha S Parikh; Suresh Antony
Journal:  J Infect Public Health       Date:  2016-01-29       Impact factor: 3.718

3.  Intraoperative Purulence Is Not Reliable for Diagnosing Periprosthetic Joint Infection.

Authors:  Pouya Alijanipour; Bahar Adeli; Erik N Hansen; Antonia F Chen; Javad Parvizi
Journal:  J Arthroplasty       Date:  2015-03-16       Impact factor: 4.757

4.  Optimal Periprosthetic Tissue Specimen Number for Diagnosis of Prosthetic Joint Infection.

Authors:  Trisha N Peel; Tim Spelman; Brenda L Dylla; John G Hughes; Kerryl E Greenwood-Quaintance; Allen C Cheng; Jayawant N Mandrekar; Robin Patel
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

5.  Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Douglas R Osmon; Elie F Berbari; Anthony R Berendt; Daniel Lew; Werner Zimmerli; James M Steckelberg; Nalini Rao; Arlen Hanssen; Walter R Wilson
Journal:  Clin Infect Dis       Date:  2013-01       Impact factor: 9.079

Review 6.  Clinical practice. Infection associated with prosthetic joints.

Authors:  Jose L Del Pozo; Robin Patel
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

7.  The EBJIS definition of periprosthetic joint infection.

Authors:  Martin McNally; Ricardo Sousa; Marjan Wouthuyzen-Bakker; Antonia F Chen; Alex Soriano; H Charles Vogely; Martin Clauss; Carlos A Higuera; Rihard Trebše
Journal:  Bone Joint J       Date:  2021-01       Impact factor: 5.082

8.  Do Culture-Negative Periprosthetic Joint Infections Have a Worse Outcome Than Culture-Positive Periprosthetic Joint Infections? A Systematic Review and Meta-Analysis.

Authors:  Marie Reisener; Carsten Perka
Journal:  Biomed Res Int       Date:  2018-07-12       Impact factor: 3.411

9.  Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients.

Authors:  Laurens Manning; Sarah Metcalf; Benjamin Clark; James Owen Robinson; Paul Huggan; Chris Luey; Stephen McBride; Craig Aboltins; Renjy Nelson; David Campbell; Lucian Bogdan Solomon; Kellie Schneider; Mark Loewenthal; Piers Yates; Eugene Athan; Darcie Cooper; Babak Rad; Tony Allworth; Alistair Reid; Kerry Read; Peter Leung; Archana Sud; Vana Nagendra; Roy Chean; Chris Lemoh; Nora Mutalima; Kate Grimwade; Marjorie Sehu; Adrienne Torda; Thi Aung; Steven Graves; David Paterson; Josh Davis
Journal:  Open Forum Infect Dis       Date:  2020-05-14       Impact factor: 3.835

10.  Predictors of Treatment Success After Periprosthetic Joint Infection: 24-Month Follow up From a Multicenter Prospective Observational Cohort Study of 653 Patients.

Authors:  Joshua S Davis; Sarah Metcalf; Benjamin Clark; J Owen Robinson; Paul Huggan; Chris Luey; Stephen McBride; Craig Aboltins; Renjy Nelson; David Campbell; L Bogdan Solomon; Kellie Schneider; Mark R Loewenthal; Piers Yates; Eugene Athan; Darcie Cooper; Babak Rad; Tony Allworth; Alistair Reid; Kerry Read; Peter Leung; Archana Sud; Vana Nagendra; Roy Chean; Chris Lemoh; Nora Mutalima; Ton Tran; Kate Grimwade; Marjoree Sehu; David Looke; Adrienne Torda; Thi Aung; Steven Graves; David L Paterson; Laurens Manning
Journal:  Open Forum Infect Dis       Date:  2022-02-02       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.